El próximo jueves 26 de marzo, a las 12:45 h a través de MS Teams, contaremos con la participación del Dr. Enrico Tongiorgi (Dpto. de Ciencias de la Vida. Universidad de Trieste, Italia) que impartirá la conferencia titulada Mirtazapine in Rett syndrome: from bench to bedside. Esta conferencia ha sido organizada por el Dr. David Baglietto del Dpto. de Biología Celular, Genética y Fisiología.
A Computational Approach to Identify Novel Protein Targets Uncovers New Potential Mechanisms of Action of Mirtazapine S(+) and R(−) Enantiomers in Rett Syndrome. Roggero OM, Gualandi N, Ciraci V, Berutto V, Carosati E, Tongiorgi E. J Neurochem. 2025. 169(5):e70093.
Selective Noradrenergic Activation of BDNF Translation by Mirtazapine. Ciraci V, Santoni L, Tongiorgi E. Mol Neurobiol. 2025. 62(5):5452-5465.
24-h continuous non-invasive multiparameter home monitoring of vitals in patients with Rett syndrome by an innovative wearable technology: evidence of an overlooked chronic fatigue status. Leoncini S, Boasiako L, Di Lucia S, et al. Front Neurol. 2024. 15:1388506.
Chemical LTP induces confinement of BDNF mRNA under dendritic spines and BDNF protein accumulation inside the spines. Bimbi G, Tongiorgi E. Front Mol Neurosci. 2024. 17:1348445.
Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes. Flores Gutiérrez J, Natali G, Giorgi J, De Leonibus E, Tongiorgi E. Exp Neurol. 2022. 353:114056.
